Midkine: A Novel Biomarker to Predict Malignancy in Patients with Nodular Thyroid Disease

Background. Midkine (MK), a new heparin-binding growth factor, plays important roles in a variety of biological phenomena such as carcinogenesis, inflammation, and angiogenesis. In this study, we aimed to evaluate serum midkine (SMK) and nodular midkine (NMK) levels in patients with thyroid nodules...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Int J Endocrinol
Glavni autori: Kuzu, Fatih, Arpaci, Dilek, Unal, Mustafa, Altas, Ayfer, Haytaoglu, Gürkan, Can, Murat, Barut, Figen, Kokturk, Furuzan, Ilikhan, Sevil Uygun, Bayraktaroglu, Taner
Format: Artigo
Jezik:Inglês
Izdano: Hindawi Publishing Corporation 2016
Teme:
Research Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4944023/
https://ncbi.nlm.nih.gov/pubmed/27446208
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2016/6035024
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items